138 related articles for article (PubMed ID: 7579330)
1. Role of light chain variable region in myeloma with light chain deposition disease: evidence from an experimental model.
Khamlichi AA; Rocca A; Touchard G; Aucouturier P; Preud'homme JL; Cogné M
Blood; 1995 Nov; 86(10):3655-9. PubMed ID: 7579330
[TBL] [Abstract][Full Text] [Related]
2. Structural peculiarities of a truncated V kappa III immunoglobulin light chain in myeloma with light chain deposition disease.
Decourt C; Cogné M; Rocca A
Clin Exp Immunol; 1996 Nov; 106(2):357-61. PubMed ID: 8918585
[TBL] [Abstract][Full Text] [Related]
3. Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.
Cogné M; Preud'homme JL; Bauwens M; Touchard G; Aucouturier P
J Clin Invest; 1991 Jun; 87(6):2186-90. PubMed ID: 1904072
[TBL] [Abstract][Full Text] [Related]
4. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status.
Yachimovich N; Mostoslavsky G; Yarkoni Y; Verbovetski I; Eilat D
Eur J Immunol; 2002 Apr; 32(4):1164-74. PubMed ID: 11932924
[TBL] [Abstract][Full Text] [Related]
5. Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance.
Sahota SS; Leo R; Hamblin TJ; Stevenson FK
Blood; 1996 Jan; 87(2):746-55. PubMed ID: 8555499
[TBL] [Abstract][Full Text] [Related]
6. Primary structure of a variable region of the V kappa I subgroup (ISE) in light chain deposition disease.
Rocca A; Khamlichi AA; Aucouturier P; Noël LH; Denoroy L; Preud'homme JL; Cogné M
Clin Exp Immunol; 1993 Mar; 91(3):506-9. PubMed ID: 7680298
[TBL] [Abstract][Full Text] [Related]
7. Cloning and sequencing of the VH and V kappa genes of an anti-CD3 monoclonal antibody, and construction of a mouse/human chimeric antibody.
Arakawa F; Kuroki M; Kuwahara M; Senba T; Ozaki H; Matsuoka Y; Misumi Y; Kanda H; Watanabe T
J Biochem; 1996 Sep; 120(3):657-62. PubMed ID: 8902633
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.
Vidal R; Goñi F; Stevens F; Aucouturier P; Kumar A; Frangione B; Ghiso J; Gallo G
Am J Pathol; 1999 Dec; 155(6):2009-17. PubMed ID: 10595931
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for expression of the A48 regulatory idiotope on antibodies encoded by immunoglobulin variable-region genes from various families.
Zaghouani H; Bonilla FA; Meek K; Bona C
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2341-5. PubMed ID: 2494665
[TBL] [Abstract][Full Text] [Related]
10. Somatic diversification is required to generate the V kappa genes of MOPC 511 and MOPC 167 myeloma proteins.
Gershenfeld HK; Tsukamoto A; Weissman IL; Joho R
Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7674-8. PubMed ID: 6801657
[TBL] [Abstract][Full Text] [Related]
11. Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells.
Sahota SS; Leo R; Hamblin TJ; Stevenson FK
Blood; 1997 Jan; 89(1):219-26. PubMed ID: 8978295
[TBL] [Abstract][Full Text] [Related]
12. Cloning of the antibody kappa light chain V-gene from murine hybridomas by bypassing the aberrant MOPC21-derived transcript.
Juste M; Muzard J; Billiald P
Anal Biochem; 2006 Feb; 349(1):159-61. PubMed ID: 16325758
[No Abstract] [Full Text] [Related]
13. Original and artificial antibodies.
Gherardi E; Milstein C
Nature; 1992 May; 357(6375):201-2. PubMed ID: 1589019
[No Abstract] [Full Text] [Related]
14. Nucleotide sequences of the variable regions of a mouse monoclonal antibody MRK16.
Hamada H; Maezawa K; Tsuruo T
Nucleic Acids Res; 1990 Apr; 18(7):1900. PubMed ID: 2110659
[No Abstract] [Full Text] [Related]
15. Comparison of two functional kappa light-chain transcripts amplified from a hybridoma.
Yang J; Zhu H; Tan Z; He F; Sun X; Hong Y; Hu H; Bian J; Lin Y; Lei P; Shen G
Biotechnol Appl Biochem; 2013; 60(3):289-97. PubMed ID: 23631518
[TBL] [Abstract][Full Text] [Related]
16. Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor.
Colombat M; Mal H; Copie-Bergman C; Diebold J; Damotte D; Callard P; Fournier M; Farcet JP; Stern M; Delfau-Larue MH
Blood; 2008 Sep; 112(5):2004-12. PubMed ID: 18483396
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic analysis of the V kappa Ser group associated with two mouse light chain genetic markers. Complementary DNA cloning and southern hybridization analysis.
Goldrick MM; Boyd RT; Ponath PD; Lou SY; Gottlieb PD
J Exp Med; 1985 Aug; 162(2):713-28. PubMed ID: 3926938
[TBL] [Abstract][Full Text] [Related]
18. Evidence for antigen driven selection in two monoclonal auto-antibodies derived from nonobese diabetic mice.
Pléau JM; Marche PN; Serrano MP; Boitard C; Bach JF
Mol Immunol; 1993 Oct; 30(14):1257-64. PubMed ID: 8413326
[TBL] [Abstract][Full Text] [Related]
19. Selective PCR amplification of functional immunoglobulin light chain from hybridoma containing the aberrant MOPC 21-derived V kappa by PNA-mediated PCR clamping.
Cochet O; Martin E; Fridman WH; Teillaud JL
Biotechniques; 1999 May; 26(5):818-20, 822. PubMed ID: 10337468
[No Abstract] [Full Text] [Related]
20. Functional and non-functional joining in immunoglobulin light chain genes of a mouse myeloma.
Altenburger W; Steinmetz M; Zachau HG
Nature; 1980 Oct; 287(5783):603-7. PubMed ID: 6776411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
